Current Controversies in the Management of MRONJ
Includes a Live Web Event on 06/20/2024 at 6:00 PM (CDT)
-
You must log in to register
- Member - $125
- Resident Member - Free!
- Allied Staff Member - $125
- Professional Staff Nonmember - $200
- Other Nonmember - $200
Current Controversies in the Management of MRONJ
Medication-related osteonecrosis of the jaw (MRONJ) is a serious complication of antiresorptive medications used for treating cancer and metabolic bone diseases. Difficulties in diagnosis, prevention and treatment exist and can lead to providers being hesitant to treat patients on these medications. This 60-minute webinar will discuss current controversies in the management of MRONJ, including review of AAOMS’s Medication-Related Osteonecrosis of the Jaw – 2022 Update Position Paper. Experts will provide actionable strategies for oral and maxillofacial surgeons.
Learning Objectives
At the conclusion of this program, participants should be able to:
- Analyze updates from the 2022 AAOMS MRONJ Position Paper on prevalence and etiology of medication-related osteonecrosis of the jaw.
- Determine available non-opioid alternatives.
- Discuss strategies to prevent MRONJ development in patients with cancer and osteoporosis.
- Examine areas of consensus and controversy in the management of MRONJ.
Cancellation Policy: Registrants will receive a full refund up until the day before the event. No refund will be given on the day of or after the event.
Tara L. Aghaloo, DDS, MD, PhD
Professor
UCLA School of Dentistry
Disclosure(s): Amgen: Research Grant or Support (Terminated, February 21, 2023); Radius Health: Research Grant or Support (Ongoing)
Brent B. Ward, DDS, MD, FACS
Section Head and Chair
Michigan Medicine/School of Dentistry/University of Michigan
Disclosures: No relevant financial relationships were disclosed.
Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.
ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).
AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680
The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Association of Oral and Maxillofacial Surgeons designates this internet-based live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.